1. Home
  2. VSTS vs OPK Comparison

VSTS vs OPK Comparison

Compare VSTS & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vestis Corporation

VSTS

Vestis Corporation

HOLD

Current Price

$11.99

Market Cap

1.0B

Sector

N/A

ML Signal

HOLD

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.10

Market Cap

921.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTS
OPK
Founded
1936
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
921.2M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
VSTS
OPK
Price
$11.99
$1.10
Analyst Decision
Sell
Hold
Analyst Count
4
3
Target Price
$5.88
$1.60
AVG Volume (30 Days)
1.0M
2.1M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,734,839,000.00
$606,879,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.67
$4.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.98
$0.98
52 Week High
$10.38
$1.60

Technical Indicators

Market Signals
Indicator
VSTS
OPK
Relative Strength Index (RSI) 78.26 37.19
Support Level $7.24 $0.98
Resistance Level N/A $1.25
Average True Range (ATR) 0.43 0.04
MACD 0.06 -0.01
Stochastic Oscillator 86.40 43.48

Price Performance

Historical Comparison
VSTS
OPK

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Share on Social Networks: